Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon

Eigenglass vs Lets Talk Clots Utilisation & Stats

Eigenglass is an augmented reality camera app used to view 3D representations of eigenmodes. The application supplements an academic research paper, providing engaging visualisations to enhance the reading experience.
  • Apple App Store
  • Gratuit
  • Éducation

Classement dans le store

- -

This app provides information for individuals who may be at risk of or who have had a blood clot - also known as a 'thrombosis' / 'deep vein thrombosis' (DVT) / 'pulmonary embolism' (PE) or a 'venous thromboembolism' (VTE). All information is medically approved and has been developed in collaboration between UK patients and healthcare providers. The app shares key information about clots, reducing risk, signs, symptoms and diagnosis as well as recovery following a VTE diagnosis. The app includes sections on approved treatments and therapies, pain and ongoing symptom management. Have been diagnosed? Information is also available about recovery, including managing anxiety and worry, regaining wellbeing, fitness and returning to everyday activities. Life after a blood clot diagnosis, includes considerations around life events, including pregnancy, family planning, travel, work and managing other conditions alongside risk factors or a personal medical history of thrombosis.
  • Apple App Store
  • Gratuit
  • Éducation

Classement dans le store

- -

Comparaison des classements Eigenglass vs. Lets Talk Clots

Comparez l'évolution du classement de Eigenglass au cours des 28 derniers jours à celle de Lets Talk Clots.

Rank

Aucune donnée disponible

Comparaison des classements Eigenglass et Lets Talk Clots par pays

Comparez l'évolution du classement de Eigenglass au cours des 28 derniers jours à celle de Lets Talk Clots.

Aucune donnée à afficher

Comparez avec n'importe quel site grâce à notre essai gratuit

Démarrer
Eigenglass VS.
Lets Talk Clots

janvier 10, 2026